Becker's Healthcare March 26, 2025
Jersey City, N.J.-based Character Biosciences has raised $93 million in a series B financing round.
The funding will be used to advance the company’s pipeline of therapies to treat degenerative eye diseases, starting with age-related macular degeneration, according to a March 25 news release from the company.
Character Biosciences has partnered with more than 150 ophthalmology treatment centers across...